These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30254187)

  • 1. Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.
    Azhar A; Kim YJ; Haider A; Hui D; Balankari VR; Epner MC; Park M; Liu DD; Williams J; Frisbee-Hume SE; Allo JA; Bruera E
    Oncologist; 2019 Jan; 24(1):125-131. PubMed ID: 30254187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced
    Fan R; Li X; Yang S; Bu X; Chen Y; Wang Y; Qiu C
    Pain Res Manag; 2022; 2022():8943292. PubMed ID: 35463627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study.
    Yen TY; Chiou JF; Chiang WY; Su WH; Huang MY; Hu MH; Wu SC; Lai YL
    Medicine (Baltimore); 2018 Jul; 97(30):e11593. PubMed ID: 30045291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard therapy with opioids in chronic pain management : ORTIBER study.
    Gatti A; Reale C; Occhioni R; Luzi M; Canneti A; De Polo C; Gubernari M; Mammucari M; Fabrizio Sabato A
    Clin Drug Investig; 2009; 29 Suppl 1():17-23. PubMed ID: 19445551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A New Therapeutic Approach for Cancer-Related Breakthrough Pain - Focused on Oral Transmucosal Fentanyl].
    Yomiya K; Kaneshima M; Kyosaka B; Warita E; Hosonuma R; Osato S
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):289-293. PubMed ID: 28428506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
    Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
    Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose titration study of fentanyl buccal soluble film for breakthrough cancer pain in Taiwan.
    Chiou TJ; Chao TC; Chao TY; Huang JS; Chang YF; Wang CH
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1179. PubMed ID: 32721110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.
    Reddy A; Yennurajalingam S; Desai H; Reddy S; de la Cruz M; Wu J; Liu D; Rodriguez EM; Waletich J; Shin SH; Gayle V; Patel P; Dalal S; Vidal M; Tanco K; Arthur J; Tallie K; Williams J; Silvestre J; Bruera E
    Oncologist; 2014 Nov; 19(11):1186-93. PubMed ID: 25342316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
    Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
    J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sublingual fentanyl orally disintegrating tablets in patients with breakthrough pain: multicentre prospective study.
    Guitart J; Vargas I; De Sanctis V; Ferreras J; Fuentes J; Salazar R; Vázquez JM; Folch J; Moya J; Ribera H; Rodelas F; Tomás A; Arilla M; Coma J; Aberasturi T; Sintes D; Lombán E
    Clin Drug Investig; 2013 Sep; 33(9):675-83. PubMed ID: 23881567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
.
    Brant JM; Rodgers BB; Gallagher E; Sundaramurthi T
    Clin J Oncol Nurs; 2017 Jun; 21(3 Suppl):71-80. PubMed ID: 28524907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK; Messina J; Xie F; Peppin J
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids for the management of breakthrough pain in cancer patients.
    Zeppetella G; Davies AN
    Cochrane Database Syst Rev; 2013 Oct; (10):CD004311. PubMed ID: 24142465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
    Hashemi M; Zali A; Golmakani E; Delshad MH; Shadnoush M; Akbari ME
    Daru; 2021 Jun; 29(1):51-59. PubMed ID: 33475984
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.